The G20 Global Pharma Summit Series-Canada has brought to the forefront the critical role of Patient Engagement in improving healthcare outcomes. This summit series, a gathering of global pharmaceutical leaders, emphasizes the need for active patient involvement in healthcare decisions.
Engaged patients, who actively participate in their healthcare journey, have been shown to have better health outcomes. They are more likely to adhere to treatment plans, leading to improved disease management and reduced healthcare costs. The summit highlights the importance of leveraging digital health technologies to enhance patient engagement.
Tools such as mobile health apps, telemedicine, and patient portals can empower patients with access to their health information, promote communication with healthcare providers, and facilitate self-management of health conditions. The G20 Global Pharma Summit Series-Canada underscores the need for healthcare systems, policymakers, and the pharmaceutical industry to collaborate in promoting patient engagement strategies for improved healthcare outcomes.